The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma.
نویسنده
چکیده
Inhaled corticosteroids, such as beclomethasone dipropionate (BDP), are well recognized as the most effective antiinflammatory drugs currently available for the treatment of chronic asthma. Research to obtain effective and welltolerated asthma therapies has led to improvements in the delivery systems and formulations of inhaled corticosteroids and to the development of new steroid agents. This article outlines the history of inhaled steroids from early studies with BDP to the recent advances in inhaled corticosteroid therapy. It then goes on to examine the relative clinical effectiveness of the new and improved formulation of BDP, hydrofluoroalkane134a (HFA)-BDP extrafine aerosol, with the new steroid, fluticasone propionate (FP).
منابع مشابه
Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
BACKGROUND To evaluate whether hydrofluoroalkane-beclomethasone dipropionate (HFA-BDP) controls eosinophilic inflammation, including that in the distal airways, more effectively than fluticasone propionate (FP) Diskus. METHODS Fifty patients with well-controlled mild to moderate persistent asthma using FP for more than 6 months were randomly assigned to FP and HFA-BDP groups, and the treatmen...
متن کاملComparison of Effectiveness between Beclomethasone Dipropionate and Fluticasone Propionate in Treatment of Children with Moderate Asthma
Asthma is a common chronic disease. Beclomethasone dipropionate (BDP) and Fluticasone propionate (FP) are 2 inhaled corticosteroids that frequently be used in treatment of patients with asthma. In this study, the effectiveness of BDP and FP in management of asthmatic children was investigated. In this trial, 50 children with moderate persistent asthma were randomly selected to receive either BD...
متن کاملCost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma.
BACKGROUND Asthma is a chronic disease characterized by acute symptomatic episodes with variable severity and duration. Pharmacological asthma management aims to achieve and maintain control without side effects, thus improving quality of life and reducing the economic impact. Recently, a clinical trial showed the non-inferiority of beclomethasone/formoterol (BDP/F) versus fluticasone propionat...
متن کاملAnalysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey-Effects of Age, Gender, and Disease Severity.
BACKGROUND Inhaled corticosteroid (ICS) has played an important role in the management of asthma. Although several kinds of ICSs are currently available, there is no established strategy for ICS selection. METHODS Using the data from the 2004 questionnaire surveys by the Niigata Asthma Treatment Study Group, we analyzed relationships between each patient and the ICS employed on the basis of p...
متن کاملImproved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
BACKGROUND Extrafine aerosols may improve asthma symptom control through increased lung deposition of medication to inflamed peripheral airways. METHODS The effect of switching patients with asthma maintained on up to 2000 microg/day chlorofluorocarbon-beclomethasone dipropionate (CFC-BDP), 1600 microg/day budesonide, 1000 microg/day fluticasone, or 2000 microg/day flunisolide, to a reduced d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Respiratory medicine
دوره 94 Suppl D شماره
صفحات -
تاریخ انتشار 2000